588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Gemtuzumab Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P4	A (81)
Posaconazole Acute Myeloid Leukemia	AstraZeneca	P4	BBB (74)
(+)-Vincristine Acute Myeloid Leukemia	Janssen Research & Development, LLC	P3	BBB (74)
Aclacinomycin Acute Myeloid Leukemia	Chinese PLA General Hospital	P4	BB (71)
Cediranib Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P3	BB (70)
Prednisone Acute Myeloid Leukemia	Children's Oncology Group	P3	BB (70)
Azacitidine Acute Myeloid Leukemia	European Organisation for Research and Treatment of Cancer - EORTC	P4	BB (69)
Busulfanum Acute Myeloid Leukemia	Sawa Ito, MD	P4	BB (69)
Cyclosporin A Acute Myeloid Leukemia	City of Hope Medical Center	P4	BB (69)
Daunomycin Acute Myeloid Leukemia	Shen yang	P4	BB (69)
Idarubicin Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P4	BB (69)
Venetoclax Acute Myeloid Leukemia	European Organisation for Research and Treatment of Cancer - EORTC	P4	BB (69)
Etoposide Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P4	BB (68)
Fludarabine Acute Myeloid Leukemia	City of Hope Medical Center	P4	BB (68)
Cladribine Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P4	BB (67)
Cyclophosphamide Acute Myeloid Leukemia	City of Hope Medical Center	P3	BB (67)
Cytarabine Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P4	BB (67)
Decitabine Acute Myeloid Leukemia	National Cancer Institute (NCI)	P4	BB (67)
Gemtuzumab Ozogamicin Acute Myeloid Leukemia	German Cancer Research Center	P3	BB (67)
Methotrexate Acute Myeloid Leukemia	Children's Oncology Group	P3	BB (67)
Mitoxantrone Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P4	BB (67)
Nivestim Acute Myeloid Leukemia	City of Hope Medical Center	P4	BB (67)
Plerixafor Acute Myeloid Leukemia	Washington University School of Medicine	P2	BB (67)
Tretinoin Acute Myeloid Leukemia	The First Affiliated Hospital of Soochow University	P3	BB (67)
Alemtuzumab Acute Myeloid Leukemia	University Hospital Tuebingen	P2/3	BB (66)
Ciprofloxacin Acute Myeloid Leukemia	Gadjah Mada University	P4	BB (66)
Nk Cell Acute Myeloid Leukemia	Hospital de Clinicas de Porto Alegre	P2	BB (66)
Olutasidenib Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P4	BB (66)
Ondansetron Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P3	BB (66)
Pevonedistat Acute Myeloid Leukemia	University of Leipzig	P3	BB (66)
Tacrolimus Acute Myeloid Leukemia	City of Hope Medical Center	P3	BB (66)
Tislelizumab Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	BB (66)
Vorinostat Acute Myeloid Leukemia	Medical College of Wisconsin	P3	BB (66)
Vosaroxin Acute Myeloid Leukemia	University of Ulm	P3	BB (66)
Gilteritinib Acute Myeloid Leukemia	European Organisation for Research and Treatment of Cancer - EORTC	P3	BB (65)
Gm-Csf Acute Myeloid Leukemia	David Avigan	P4	BB (65)
Astx727 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P3	BB (64)
Glasdegib Acute Myeloid Leukemia	City of Hope Medical Center	P3	BB (64)
Naxtarubicin Acute Myeloid Leukemia	Moleculin Biotech, Inc.	P2/3	BB (64)
Thiotepa Acute Myeloid Leukemia	Sawa Ito, MD	P3	BB (64)
Aclarubicin Acute Myeloid Leukemia	Shanghai Jiao Tong University School of Medicine	P3	B (63)
Dexasone Acute Myeloid Leukemia	Janssen Research & Development, LLC	P4	B (63)
Lisaftoclax Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	P3	B (63)
Melphalan Acute Myeloid Leukemia	City of Hope Medical Center	P4	B (63)
Mylotarg Acute Myeloid Leukemia	Shaare Zedek Medical Center	P4	B (63)
Peripheral Blood Stem Cells, Allogeneic, Cd34 Positive Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2/3	B (63)
Quizartinib Acute Myeloid Leukemia	Daiichi Sankyo	P3	B (63)
Revumenib Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P3	B (63)
Ruserontinib Acute Myeloid Leukemia	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P3	B (63)
Thioguanine Anhydrous Acute Myeloid Leukemia	Columbia University	P3	B (63)

Showing 1 to 50 of 588 assets

PreviousPage 1 of 12Next